Yishan Peter Li

Bio

Yishan (Peter) Li, Ph.D., M.B.A., is a Vice President at Kenson Ventures, LLC. Dr. Li has extensive business and scientific experience. At his current position, he consulted for biotech startups on business strategies, operations, marketing and business development in his capacities as a member of Board of Directors, an observer to the Board, or a business advisor. He worked in biotechnology corporate finance at investment bank RBC Capital Markets while he was in business school. Prior to business school, he was the head of Peptide Antibody Development at Santa Cruz Biotechnology, Inc. Prior to that, he was a postdoctoral research fellow at the Department of Molecular and Cell Biology, University of California, Berkeley. Dr. Li's scientific work focused on protein expression, small molecule-protein interaction, protein structure-function relationship, and mechanisms of enzymes. Dr. Li earned his M.B.A. from University of California, Berkeley. He received his Ph.D. in biochemistry from Ohio State University, where he was a University Presidential Fellow, and his B.S. from University of Science and Technology of China. Peter is on leave at Epitomics, Inc.